Presenter(s):
Topic(s):
Myelodysplastic Syndromes (MDS)
Presentation Date:
Fri, 09/20/2019 - 8:00pm (EDT)
Dr. Marlise Luskin from Dana Farber Cancer Institute defines high-risk MDS versus low-risk MDS, impact for patients and what treatment options are available.